Cantitate/Preț
Produs
Total produse
Vezi coșul
Neuropsychotherapeutics de Jeffrey M. Witkin

Neuropsychotherapeutics: Advances in Pharmacology, cartea 86

Jeffrey M. Witkin
en Limba Engleză Hardback – 31 iul 2019
Neuropsychotherapeutics, Volume 86, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field, with this updated edition including sections on Pharmacotherapy of psychiatric disorders, Allosteric mechanisms for neuropsychopharmacology, Lipid rafts, Rapid-acting antidepressants, mGlu2/3 receptor antagonists, Nitric oxide: antidepressant mechanisms and inflammation, Anxiety disorders, mGlu receptors and schizophrenia, mAChR ligands for schizophrenia and addiction, PDE10 inhibitors, Obsessive-compulsive disorder, Addiction disorders (including eating), Dopamine D1 PAMs as a New Mode for Treatment of Neuropsychiatric Disorders, and more.


  • Includes the authority and expertise of leading contributors in pharmacology
  • Presents the latest release in the Advances in Pharmacology series
Citește tot Restrânge

Din seria Advances in Pharmacology

Preț: 106843 lei

Preț vechi: 151214 lei
-29% Nou

Puncte Express: 1603
Preț estimativ în valută:
20451€ • 21444$ • 16898£

Carte tipărită la comandă

Livrare economică 22 ianuarie-05 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128166680
ISBN-10: 0128166681
Pagini: 320
Dimensiuni: 152 x 229 x 25 mm
Greutate: 0.59 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology

Public țintă

investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.

Cuprins

1. GPCR drug discovery-moving beyond the orthosteric to the allosteric domainChristian C. Felder2. Lipid rafts in psychiatryNathan H. Wray and Mark M. Rasenick3. Rapid-acting antidepressantsJeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith4. mGlu2/3 receptor antagonistsShigeyuki Chaki5. Nitric oxide: Antidepressant mechanisms and inflammationMehdi Ghasemi6. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disordersLaura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones7. Medications development for food-based and drug use disordersFernando B. de Moura, Stephen J. Kohut and Jack Bergman8. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic researchErik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman9. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disordersKjell A. Svensson, Junliang Hao and Robert F. Bruns